financetom
Business
financetom
/
Business
/
DynaCERT Appoints New President; CEO Assumes Chairman Role
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DynaCERT Appoints New President; CEO Assumes Chairman Role
May 13, 2024 4:09 AM

06:40 AM EDT, 05/13/2024 (MT Newswires) -- DynaCERT ( DYFSF ) , a developer of carbon emission reduction technology, said Monday that Chief Executive Jim Payne stepped down as president of the company.

The company has tapped Bernd Krueper as its new president and as director.

Payne has succeeded Wayne Hoffman as board chairman. Hoffman will continue to serve on the board as lead director.

Krueper joins the company with more than 30 years of experience in international leadership roles in the automotive and off-highway industry, as well as in sustainable energy and power generation services and precision machining.

The new appointments are effective May 15. Also, the board size has been increased to nine directors from eight.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Fed's Mixed Messaging, AI Hype
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Fed's Mixed Messaging, AI Hype
Sep 24, 2025
08:52 AM EDT, 09/24/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.2% in Wednesday's premarket activity, as gains in Alibaba ( BABA ) helped offset the lingering uncertainty from Fed Chair Jerome Powell's remarks. US stock futures were also...
Harmony Biosciences Says Late-Study Trial of ZYN002 to Treat Fragile X Syndrome Misses Primary Endpoint
Harmony Biosciences Says Late-Study Trial of ZYN002 to Treat Fragile X Syndrome Misses Primary Endpoint
Sep 24, 2025
08:54 AM EDT, 09/24/2025 (MT Newswires) -- Harmony Biosciences ( HRMY ) said Wednesday that its late-stage trial of ZYN002 to treat Fragile X syndrome has missed its primary endpoint. The company said the drug did not meet the primary endpoint of improving social avoidance primarily due to a higher-than-expected placebo response rate. Harmony said it will conduct a comprehensive...
Axcap Ventures Closes C$12.5 Million Concurrent Offering in Relation to Taura Gold Deal
Axcap Ventures Closes C$12.5 Million Concurrent Offering in Relation to Taura Gold Deal
Sep 24, 2025
08:54 AM EDT, 09/24/2025 (MT Newswires) -- Axcap Ventures ( GARLF ) overnight Tuesday announced that it has closed a non-brokered private placement arranged in connection with an arrangement agreement that will see Axcap ( GARLF ) acquire all of the issued and outstanding common shares of Taura Gold (TORA.V). The concurrent offering included 125 million common shares in the...
Sector Update: Consumer
Sector Update: Consumer
Sep 24, 2025
08:53 AM EDT, 09/24/2025 (MT Newswires) -- Consumer stocks were advancing premarket Wednesday, with the Consumer Staples Select Sector SPDR Fund (XLP) 0.1% higher and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.4%. Alibaba Group ( BABA ) plans to increase its spending on artificial intelligence development as the Chinese e-commerce giant looks to become a full-stack AI...
Copyright 2023-2026 - www.financetom.com All Rights Reserved